Background Findings of retrospective studies suggest that sorafenib maintenance post-
transplantation might reduce relapse in patients with FLT3 internal tandem duplication (FLT3 …

Background Adults with acute myeloid leukaemia have unsatisfactory clinical outcomes and
rates of complete remission. Venetoclax combined with azacytidine or low-dose cytarabine …

Background Burkholderia cepacia (BC) has been detected more and more in infected
patients in recent years. However, as a high-risk population, the clinical characteristics and …

To evaluate the efficacy of interferon-α (IFN-α) as maintenance therapy in patients with
favorable-risk acute myeloid leukemia (AML), this retrospective study enrolled 84 patients …

Abstract Background Venetoclax (Ven) combined with intensive chemotherapy was proven
effective in the management of acute myeloid leukemia (AML). However, the severe and …

Normal karyotype acute myeloid leukemia (NK-AML) is a highly heterogeneous malignancy
that resides within a complex immune microenvironment, complicating efforts to reveal the …

Acute myeloid leukemia (AML) outcomes are very poor in older patients. Haploidentical
stem cell transplantation (haplo-SCT) helps to achieve long-term survival. However, the …

Introduction The heterogeneity of treatment response in acute myeloid leukemia (AML)
patients poses great challenges for risk scoring and treatment stratification. Carbohydrate …

Background Identifying therapeutic targets and prognostic biomarkers significantly
contributes to individualized treatment of acute myeloid leukemia (AML) …

Background Spermatogenesis associated serine rich 2 like (SPATS2L) was highly
expressed in homoharringtonine (HHT) resistant acute myeloid leukemia (AML) cell lines …